Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis

International Journal of Infectious Diseases

Volumn 94, Issue , 2020, Pages 91-95

  Yang, Jing ^a   Zheng, Ya ^a   Gou, Xi ^a   Pu, Ke ^a   Chen, Zhaofeng ^a   Guo, Qinghong ^a   Ji, Rui ^a   Wang, Haojia ^a   Wang, Yuping ^a   Zhou, Yongning ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Clinical characteristics; Comorbidities; COVID 19; Epidemiology; Meta analysis; SARS CoV 2

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CORONAVIRUS DISEASE 2019; COUGHING; DIABETES MELLITUS; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEVER; HUMAN; HYPERTENSION; INFECTION RISK; PREVALENCE; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SYSTEMATIC REVIEW; BETACORONAVIRUS; CORONAVIRUS INFECTION; META ANALYSIS; PANDEMIC; RISK FACTOR; VIRUS PNEUMONIA;

BETACORONAVIRUS; COMORBIDITY; CORONAVIRUS INFECTIONS; COUGH; FEVER; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; PREVALENCE; RISK FACTORS;

EID: 85082774948     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2020.03.017     Document Type: Article

References (23)

1. Alraddadi, B.M., Watson, J.T., Almarashi, A., Abedi, G.R., Turkistani, A., Sadran, M., et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerging Infect Dis 22 (2016), 49–55.
2. Badawi, A., Ryoo, S.G., Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis 49 (2016), 129–133.
3. Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P.P., Meyerholz, D.K., Perlman, S., Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 198 (2017), 4046–4053.
4. Dooley, K.E., Chaisson, R.E., Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9 (2009), 737–746.
5. Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 2020, 10.1056/NEJMoa2002032.
6. Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q., Zhou, M., et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score. Front Microbiol, 10, 2019, 2752.
7. Hong, K.W., Cheong, H.J., Choi, W.S., Lee, J., Wie, S.H., Baek, J.H., et al. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemothe 20 (2014), 9–14.
8. Hu, S., Gao, R., Liu, L., Zhu, M., Wang, W., Wang, Y., et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circ J, 34, 2019, 209.
9. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
10. Hui, D.S., IA, E., Madani, T.A., Ntoumi, F., Kock, R., Dar, O., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91 (2020), 264–266.
11. Jaillon, S., Berthenet, K., Garlanda, C., Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 56 (2019), 308–321.
12. Lau, D., Eurich, D.T., Majumdar, S.R., Katz, A., Johnson, J.A., Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. Thorax 68 (2013), 658–663.
13. Liu, K., Fang, Y.Y., Deng, Y., Liu, W., Wang, M.F., Ma, J.P., et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J, 2020, 10.1097/cm9.0000000000000744.
14. Liu, M., Liu, S.W., Wang, L.J., Bai, Y.M., Zeng, X.Y., Guo, H.B., et al. Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study. Diabetes Metab 45 (2019), 286–293.
15. Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63 (2020), 364–374.
16. Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (2020), 565–574.
17. Mertz, D., Kim, T.H., Johnstone, J., Lam, P.P., Science, M., Kuster, S.P., et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ, 347, 2013, f5061.
18. Odegaard, J.I., Chawla, A., Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harbor Perspect Med, 2, 2012, a007724.
19. Patel, A., Jernigan, D.B., Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak – United States, December 31, 2019-February 4, 2020. Am J Transpl 20 (2020), 889–895.
20. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Wkly 2 (2020), 113–122.
21. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama 323 (2020), 1061–1069.
22. Zhang, J.J., Dong, X., Cao, Y.Y., Yuan, Y.D., Yang, Y.B., Yan, Y.Q., et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy 0 (2020), 1–12.
23. Zhang, M.Q., Wang, X.H., Chen, Y.L., Zhao, K.L., Cai, Y.Q., An, C.L., et al. Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing. Zhonghua jie he he hu xi za zhi, 43, 2020, E013.